NCI10496
OPEN TO ACCRUAL
Ph 2 Study of Ipatasertib with Pembrolizumab for 1L Treatment of Recurrent or SCC of the H&N
NRGHN009
OPEN TO ACCRUAL
II/III Trial of Radiation w/ Cisplatin 100mg/m2 Q3W vs QW Cisplatin 40 mg2 for Pts w/ Loco Adv SCCHN
UW21144
OPEN TO ACCRUAL
Phase 1 + dose expansion of MSC in patients with Xerostomia post RT In H&N cancer
UW23121
OPEN TO ACCRUAL
Pilot Study of INCB081776